Shaping the Future of Care
With our international scale and reach, IHH is taking the lead in innovation. We partner and invest in companies in the fields of healthtech and digital health to improve our healthcare services and grow our healthcare ecosystem. On the digital health front, we are expanding our capabilities globally to provide patients with faster, better, easier and more cost-effective care.
The more we disrupt ourselves as an industry, the more patients stand to gain. As they do, they trust us more and their trust is what will underpin our long-term sustainability as a business. Granted, technology alone is no substitute for professional expertise and quality care. But it is a tool we can use to create new possibilities, unveil a new reality and transform care for our patients.
Dr Kelvin Loh
Managing Director and CEO, IHH
Leveraging Artificial Intelligence
IHH is one of the first healthcare groups in the world to use artificial intelligence (AI) to estimate hospital bills. The predictive system gives our patients in Singapore more accurate and personalised bill estimations, empowering them to make better informed decisions on their treatment options.
More important, our patients get greater peace of mind over their healthcare expenditure prior to admission so that they can focus on getting well. With an 80% estimate accuracy for inpatient bills, this initiative builds trust with patients and in the longer term bend the healthcare curve.
Putting Healthcare in Your Hand
At the height of the COVID-19 pandemic, IHH moved quickly to make virtual consultations available across all our key markets of Malaysia, Singapore, Turkey, India, China and Hong Kong. Patients around the world can now enjoy greater access to our quality medical care and services, from consultation to doorstep drug delivery, from the comfort of their homes.
Across our various markets, we also integrated mobile applications into our brick-and-mortar services to give our patients easy access to appointment services, medical records and health information – with just a few clicks.
Building Strategic Partnerships
IHH collaborates with start-ups to deploy innovative and cutting-edge healthcare technology that enhances the patient experience and improves clinical outcomes through less invasive, more precise, and more affordable technology.
- The partnership with precision medicine company Lucence Health gives our patients better access to cancer diagnostics including liquid biopsy that is less invasive than tissue biopsy.
- We have grown our healthcare ecosystem and reach by investing in Doctor Anywhere, a tech-enabled omnichannel healthcare platform serving multiple countries in Asia. The partnership enables us to provide more convenient, accessible and cost-effective care to meet the growing demands of patients.
- Partnering Accredify, we are an early adopter of blockchain technology to issue tamper-proof, easily verifiable digital COVID-19 test results directly from a mobile app, as the world prepares to reopen its borders to travellers.
Did you know that IHH has a data team that recently developed and launched our very own AI-powered billing estimation tool? The in-house solution FeeAdvisor.ai has been progressively deployed in our hospitals in Malaysia.
The theme 'Quality & Innovation: Reimagined' set the stage for two awesome days of learning among staff across our global network. Find out who prevailed in the 2021 IHH Quality Summit and Innovation Challenge.
Being able to walk out of the operating theatre without any walking aid just three hours after a knee joint replacement surgery - this was made possible for a 51-year-old patient at Gleneagles Hospital Hong Kong with the help of a robotic arm...
Gleneagles Hospital Hong Kong has launched an innovative hypertension care programme that leverages technology in partnership with Hong Kong Telecom and FWD Insurance.
Gleneagles Hospital Hong Kong has partnered with FTLife Insurance Company to launch a unique medical insurance plan that offers patients greater peace of mind through more affordable and transparent healthcare services.
Congratulations to our IHH Healthcare Singapore team for bagging the coveted award for Mobile - Healthcare at the Singapore Business Review Technology Excellence Awards 2021.
To help meet the community’s demand for COVID-19 testing, Gleneagles Chengdu Hospital has launched a new nuclei acid testing service for companies and groups that takes just five minutes, with the results issued within 24 hours.
Gleneagles Chengdu Hospital turned one on 26 October. Reflecting on an eventful year marked by progressive ramp-up of hospital services, staff training and COVID-19 community relief efforts, the team looks ahead to bring...